VITAMIN D DAN DISFUNGSI ENDOTEL PADA KAKI DIABETIK

Raflis Raflis

Abstract


Globally the prevalence of type 2 Diabetes Mellitus (DM) among adult remain increase, including in Indonesia. DM with complicated condition might be cause disability that’s call diabetic foot. Diabetic foot is a leg disorder caused by uncontrolled diabetes mellitus resulting in blood vessel disorders, nervous disorders and infection. There are three main problems with diabetic foot, namely ischemia, neuropathy, and infection. These three problems, if triggered by trauma, will cause diabetic foot ulcers. Diabetic foot process initiated by their state of chronic hyperglycemia that causes inflammation in the arterial endothelium, cause endothelial dysfunction.  Many studies that suggest a relationship of vitamin D with this inflammatory process. Hipovitaminosis state D will give effect to the increasing activity of the RAAS include hypertension, increased insulin resistance and dysfunction of pancreatic cells which can lead to hyperglycemia, decreased HDL and increased triglycerides. Hypovitaminosis vitamin D can directly increase the proinflammatory cytokines that produce TNF-α. This inflammatory process would lead to decreased levels of Nitric Oxide (NO) and increased ROS. Vitamin D might be have  a role in cotrolling inflammation in endothelial cells among people with diabetic foot.

Keywords: endothelial dysfunction, diabetic foot, vitamin D


Full Text:

PDF

References


Andrukhova O, Slavic S, Zeitz U et al. 2013. Vitamin D is a Regulator of Endhotelial Nitric Oxide Synthase and Arterial Stiffness in Mice. Molecular Endocrinology. 28(1):53-64.

Avogaro A, Albiero M, Menegazzo L, De Kreutzenberg S, Fadini GP. 2011. Endothelial Dysfunction in Diabetes: The Role of Reparatory Mechanisms. Diabetes Care. 34(2):S285-90.

Boulton, Andrew J.M. 2008. The diabetic foot: Grand overview, epidemiology, and pathogenesis. Diabetes/Metabolism Research and Reviews. 24(Suppl 1):S3-6.

Casey CF, Slawson DC, Neal LR. 2008. Vitamin D Supplementation in Infants, Children, and Adolescents. AAF. 81(6):745-8.

Chagas, E, et al. 2012. Focus On Vitamin D, Inflammation and Type 2 Diabetes. Nutrients. 4:52-67.

Creager MA, Luscher TF. 2003. Diabetes and Vaskular Disease: Patophisiology, Clinical Consequences and Medical Therapy. Circulation. 108(Pt 1):11-17.

Deluca HF, Cantorna MT. 2001. Vitamin D: Its Role and Uses In Immunology.The Federation of American Societies for Experimental Biology. 15(14):2579-2585.

Dobnig H, Pilz S, Scharnagl H, Renner W, et al. 2008. Independent Association of Low Serum 25-Hydroxyvitamin D And 1, 25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality. Internal Medicine. 168(12):1340-1349.

Frykberg, Robert G, et al. 2006. Diabetic Foot Disorders: A Clinical Practice Guideline (2006 rev). The Journal of Foot & Ankle Surgery. 45(5):S1-6.

Giovannucci E, Liu Y, Hollis BW, Rimm EB. 2008. 25-Hydroxyvitamin D and Risk Of Myocardial Infarction in Men. Internal Medicine. 168(11):1174-1180.

Griz L.H.M., Bandeira F, Gabbay MAL, Dib SA, et al. 2014. Vitamin D and Diabetes Mellitus: An Update 2013. Arquivos Brasileiros De Endocrinologia & Metabologia. 58(1):1-8.

Hitmann, Graham A, et al. 1998. Vitamin D Receptor Gene Polymorphisms Influence Insulin Secretion in Bangladeshi Asians. Diabetes. 47:688-690.

Holick MF. 2007. Vitamin D Deficiency. N Engl J Med. 357:266-81.

Kemenkes RI. 2019. Riset Kesehatan Dasar 2018. Diunduh di: https://www.kemkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf pada tanggal 3 Januari 2021.

Knight L, Michie C, Geoghegan F. 2010. Vitamin D Deficiency in Children and Adults: Treatment and Prophylaxis Guideline. Guideline. London: Imperial College Healthcare and NHS Westminister.

Mathieu C, Adorini L. 2002. The Coming of Age of 1, 25-Dihydroxyvitamin D 3 Analogs as Immunomodulatory Agents. Molecular Medicine. 8(4):174-179.

Ogunkolade, et al. 2002. Vitamin D Receptor (VDR) MRNA and VDR Protein Levels in Relation to Vitamin D Status, Insulin Secretory Capacity, and VDR Genotype n Bangladeshi Asians. Diabetes. 51:2294-2300.

Palomer X, et al. 2006. Role of Vitamin D in The Pathogenesis of Type 2 Diabetes Mellitus. Diabetic, Obesity, and Metabolism. 10:185-197.

Picchi, Andrea, et al. 2006. Tumor Necrosis Factor-α Induces Endothelial Dysfunction in The Prediabetic Metabolic Syndrome. Circulation Research. 99:69-77.

Pittas AG, Lau J, Hu FB, Dawson-Hughes B. 2007. The Role of Vitamin D and Calcium in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 92(6):2017-2029 .

Simerjit, Singh, et al. 2013. Diabetic Foot Ulcer-Diagnosis and Management. Clinical Research on Foot&Ankle. 1(3):1-9.

Spina CS, Tangpricha V, Uskokovic M, Adorinic L, et al. 2006. Vitamin D and Cancer. Anticancer Research. 26(4a):2515-2524.

WHO. 2016. Global Report on Diabetes. Diunduh di: https://www.who.int/publications/i/item/9789241565257 pada tanggal 3 Januari 2021.

Yu, Fei, et al. 2016. The Genetic Polymorphism in Vitamin D Receptor and The Risk of Type 2 Diabetes Mellitus. Asia Pac.J.Clin.Nutr. 25(3):614-624.

Zhang C. 2008. The Role of Inflammatory Cytokines in Endothelial Dysfunction. Basic Res Cardiol. 103(5):398-406.

Zhang, Hanrui, et al. 2009. Role of TNF-Α in Vascular Dysfunction. Clinical Science. 116:219-230.




DOI: http://dx.doi.org/10.32883/hcj.v6i1.1077

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 HUMAN CARE JOURNAL
Published by Universitas Fort De Kock, Bukittinggi, Indonesia

© Human Care Journal  e-ISSN : 2528-665X P-ISSN : 2685-5798

View Human Care Journal Stats